This Government Contract opportunity from Department Of Defense was posted on March 18, 2022. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Fenofibrate Nanocrystalize
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract pertains to the procurement and management of Fenofibrate Nanocrystalize Tablets under solicitation number SPE2D2-20-R-0073, issued by the Department of Defense's DLA Troop Support in Philadelphia. Several modifications have been made to the contract, including P00004, which allows for a no-cost settlement termination for convenience, providing flexibility for either party to end the agreement without penalty. Modification P00003 incorporated a FAR clause (52.204-27) that prohibits the use of ByteDance-covered applications, ensuring compliance with national security requirements. The contract also includes two option years, with Option Year 1 spanning from April 5, 2022, to April 4, 2023, and Option Year 2 from April 5, 2023, to April 4, 2024, allowing for potential extension of the procurement period based on performance and need. An initial amendment extended the solicitation closing date to October 23, 2020, at 3:00 PM EDT, indicating ongoing negotiations and updates to the procurement process. The contract's NAICS code is 325412, which relates to pharmaceutical and medicine manufacturing, aligning with the product being procured. The primary point of contact is Phyllis Daraio, reachable via email or phone, and further contract details can be accessed through the provided link on SAM.gov. Overall, the contract reflects a structured procurement process with provisions for flexibility, compliance, and potential extension to meet the Department of Defense’s requirements for Fenofibrate Nanocrystalize Tablets.
General Info
Place of Performance
Mohali, PA, INDSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
Modification P00004 SPE2D2-21-D-0131 No Cost-Settlement Termination for Convenience.
Modification P00003 SPE2D2-21-D-0131 to incorporate FAR Claluse 52.204-27 Prohibition on a Bytedance Covered Application (JUN 2023) into contract.
Option Year 2 P00002 SPE2D2-21-D-0131 to invoke option period of April 05, 2023 through April 04, 2024.
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
More opportunities from Department Of Defense → DLA Troop Support
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
